Clinical Trial Update: Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder [Phase 1]

View source ↗

Summary

This completed Phase 1 study evaluated the safety and tolerability of FK949E in elderly patients with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• FK949E

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Major Depressive Disorder Patients | Phase 1 | Status: COMPLETED